Evidence map›Paper›PMID 38693303›Full record

ArticleScientific reports2024

Author Correction: Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer.

Skye Alexandre Sauriol, Euridice Carmona, Molly L Udaskin, Nikolina Radulovich, Kim Leclerc-Desaulniers, Robert Rottapel, Amit M Oza, Stephanie Lheureux, Diane M Provencher, Anne-Marie Mes-Masson

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Skye Alexandre SauriolCentre de Recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, H2X 0A9, Canada.
Euridice CarmonaCentre de Recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, H2X 0A9, Canada.
Molly L UdaskinPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Nikolina RadulovichPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Kim Leclerc-DesaulniersCentre de Recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, H2X 0A9, Canada.
Robert RottapelPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Amit M OzaPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Stephanie LheureuxPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
Diane M ProvencherCentre de Recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, H2X 0A9, Canada.
Anne-Marie Mes-MassonCentre de Recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, H2X 0A9, Canada. anne-marie.mes-masson@umontreal.ca.
University Health Network · CACentre Hospitalier de l’Université de Montréal · CAInstitute for Research in Immunology and Cancer · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38693303
PMCPMC11063060
OpenAlexW4396544296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.